Skip to content
DataLookout
Menu

NCT07886801

A Study of Ropeg-Interferon in People With Polycythemia Vera

StatusRecruiting
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Recruitment opened
    • Site details revised at 7 of 7 sites
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Proportion of patients who meet criteria for treatment discontinuation
Timeframe: 24 months

Secondary (1)

Proportion of patients who meet criteria for treatment discontinuation

Arms and interventions

Ropeg-Interferon in People With Polycythemia VeraExperimental

Each patient will receive ropeg-IFN subcutaneously.

Drugs: Ropeginterferon

Sites

7 sites in 1 country